【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q1 2013 9
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q1 2013 9
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q1 2013 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q1 2013 12
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2013 13
2.4.1 Biogen Idec To Acquire Elan’s Interest In Multiple Sclerosis Drug Tysabri For $3.25 Billion 13
2.4.2 Medtronic Completes Public Offering of Notes for $3 Billion 13
2.4.3 Cardinal Health to Acquire AssuraMed for up to $2.07 Billion 14
2.4.4 Mylan to Acquire Agila Specialties from Strides Arcolab for up to $1.85 Billion 14
2.4.5 MacroGenics Enters into Licensing Agreement with Gilead Sciences for DART Technology 14
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 15
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q1 2013 15
3.1.1 Top M&A Deals in Q1 2013 16
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q1 2012 – Q1 2013 17
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q1 2013 18
3.2.1 Top Initial Public Offerings in Q1 2013 19
3.2.2 Top Secondary Offerings in Q1 2013 19
3.2.3 Top PIPE Deals in Q1 2013 19
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q1 2012–Q1 2013 20
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q1 2012 – Q1 2013 21
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q1 2013 22
3.3.1 Top Venture Financing Deals in Q1 2013 23
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2013 24
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2013 25
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q1 2012 – Q1 2013 26
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 27
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 28
3.3.7 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q1 2013 29
3.3.8 Top Private Equity Deals in Q1 2013 30
3.3.9 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q1 2012 – Q1 2013 31
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2013 32
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2013 32
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q1 2012 – Q1 2013 34
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2013 35
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q1 2013 36
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2013 36
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q1 2013 37
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 38
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q1 2012 – Q1 2013 39
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q1 2012 – Q1 2013 40
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 41
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q1 2013 42
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q1 2013 42
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 43
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q1 2013 44
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q1 2013 44
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q1 2013 45
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q1 2012 – Q1 2013 46
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q1 2012 – Q1 2013 47
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2012 – Q1 2013 48
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2012 – Q1 2013 49
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q1 2012 – Q1 2013 50
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 51
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q1 2012 – Q1 2013 51
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q1 2012 – Q1 2013 52
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q1 2012 – Q1 2013 53
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q1 2012 – Q1 2013 54
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q1 2012 – Q1 2013 55
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q1 2012 – Q1 2013 56
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q1 2012 – Q1 2013 57
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 58
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q1 2013 58
7.1.1 Oncology – Deals of the Quarter 59
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q1 2013 60
7.2.1 Central Nervous System – Deals of the Quarter 61
7.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q1 2013 62
7.3.1 Immunology – Deals of the Quarter 63
7.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q1 2013 64
7.4.1 Infectious Disease – Deals of the Quarter 65
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q1 2013 66
7.5.1 Metabolic Disorders – Deals of the Quarter 67
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q1 2013 68
7.6.1 Cardiovascular – Deals of the Quarter 69
7.7 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q1 2013 70
7.7.1 Respiratory – Deals of the Quarter 71
7.8 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q1 2013 72
7.8.1 Gastrointestinal – Deals of the Quarter 73
7.9 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q1 2013 74
7.9.1 Ophthalmology – Deals of the Quarter 75
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q1 2013 76
7.10.1 Dermatology – Deals of the Quarter 77
8 Deal Summary by Geography 78
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q1 2013 78
8.1.1 North America – Deals of the Quarter 79
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q1 2013 80
8.2.1 Europe – Deals of the Quarter 81
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q1 2013 83
8.3.1 Asia-Pacific – Deals of the Quarter 84
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q1 2013 85
8.4.1 Rest of the World – Deals of the Quarter 86
9 Pharmaceuticals & Healthcare, Global, Top Advisors 87
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 87
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 88
10 Appendix 89
11 Further Information 92
11.1 Methodology 92
11.2 About GlobalData 93
11.3 Contact Us 93
11.4 Disclosure information 93
11.5 Disclaimer 93
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向（四半期別）：Q1 2013■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013
■ 発行日：2013年4月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160890
■ 調査対象地域：グローバル
- 世界の動物/獣医ワクチン市場The global animal vaccines market is in its growth phase and is poised to cross the $8 billion mark by 2018. The factors responsible for the growth of the market include increasing incidences of zoonotic diseases in humans; growing prevalence of animal diseases; and increasing investments by government bodies, animal welfare associations, and leading players. Another factor driving the growth in t …
- 世界の3Dプリンター市場動向（2012-2016）TechNavio's analysts forecast the Global 3D Printer market to grow at a CAGR of 16.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the demand for quick turnaround time. The Global 3D Printer market has also been witnessing the rapid growth of 3D printing among entrepreneurs and consumers. However, the increasing number of intellectual property righ …
- dL-イソクエン酸ラクトンの世界市場DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 presents comprehensive data on dl-isocitric acid lactone markets globally and regionally (Europe, Asia, North America etc.) The DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 includes dl-isocitric acid lactone description, covers its application areas and related patterns. It overviews dl-isocitric acid la …
- 世界主要国における腫瘍マーカー検査市場2015This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative arrangements Business strategies. Contains 80 pages
- 木材プラスチック複合材の世界市場2017-2021ABSTRACTAbout Wood Plastic Composites WPC is a material that is manufactured with wood coupled with a suitable polymer matrix. Compounding, extrusion, and injection molding are the commonly employed techniques for manufacturing WPCs. Wood plastic composites (WPCs) consist of natural fibers and additives compounded with a polymer matrix. These composites are manufactured using either wood and plast …
- 半導体レーザーの世界市場分：タイプ別（光ファイバーレーザー、面発光レーザー、コンパクトディスクレーザー、ハイパワーダイオードレーザー、赤色レーザー、バイオレットレーザー、グリーンレーザー、青色レーザー）、用途別（光ストレージ、リソグラフィ、ヘルスケア、研究開発および防衛、センサー、ディスプレイ、印刷、通信、工業用）、セグメント予測The global semiconductor laser market size is expected to reach USD 9.52 billion by 2024, according to a new report by Grand View Research, Inc. The surging acceptance of fiber optic lasers in the communication and connectivity verticals and the growing preference for semiconductor lasers over other light sources are expected to boost the market growth. The increasing deployment of semiconductor l …
- 中南米の圧力モニタリング市場：装置、アクセサリーThe Latin America pressure monitoring market was valued at USD 334.2 million in 2014 and is expected to reach USD 463.4 million by 2020, at a CAGR of 5.6% from 2015 to 2020. Pressure monitoring devices are classified into blood pressure monitors, pulmonary pressure monitors, and intraocular pressure monitors, and intracranial pressure monitors. Along with the devices market, the accessories market …
- 水処理装置の世界市場：軟水装置、活性炭濾過器、機械式濾過、逆浸透装置、蒸留システム、消毒装置The water treatment systems (PoE) market is projected to grow at a CAGR of 8.52% from 2015 and 2020. The growth in this market is propelled by continuous growth in industrialization, especially in developing economies, increasing water contamination, and increasing awareness about the importance of clean drinking water. The market in the Asia-Pacific region is expected to register the highest grow …
- エチレン酢酸ビニル(EVA)の世界市場予測Ethylene-vinyl acetate 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about ethylene-vinyl acetate market in the all-in-one report issued in a logical and easily accessible format. In addition to …
- 世界のPCB市場動向（2012-2016）TechNavio's analysts forecast the Global Printed Circuit Board (PCB) market to grow at a CAGR of 7.8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of smartphones and tablet PCs. The Global PCB market has also been witnessing the increasing demand for miniaturized PCBs. However, increasing raw materials prices could pose a ch …
- Gastroenteritis：グローバル臨床試験レビューH2, 2013Gastroenteritis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, H2, 2013" provides data on the Gastroenteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastroenteritis. It includes an overview of the trial numbers and their recruitment status as …
- Imperial Oil Limited社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Imperial Oil Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Imperial Oil Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 2014年戦略提言：Malaria診断検査市場The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerci …
- 世界の核酸検査及びDNAシーケンシング市場2014This report provides:Estimates of facilities performing DNA sequencing and molecular diagnostic testing in France, Germany, Italy, Japan, Spain, UK and USA.Five-year test volume and sales forecasts by country. List of TablesTable 1. Laboratories Performing DNA Sequencing By Country Table 2. NAT Testing: Potential Laboratory Universe by Country Table 3. NAT Test Volume Forecasts b …
- 世界の骨成長刺激装置市場2015The Global Bone Growth Stimulators Industry Report 2015 is a professional and in-depth study on the current state of the Bone Growth Stimulators industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Bone Growth Stimulators market analysis is provided for the international markets including development tr …
